AzTrials
AzTrials

Psychiatric DisorderNCT04574986

Description of the Psychiatric Care Pathway of Pregnant Women After the Early Prenatal Interview

An observational study of Psychiatric Disorder, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pregnancy and postpartum are recognized as periods of psychic fragility. However, the psychiatric disorders of women that can emerge during these periods are underdiagnosed and have consequences in particular on the development of the child, his relationship with his parents. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Psychiatric Disorder
How many people
1,000 participants
Where
1 siteFrance
Study dates
1 Mar 2019to 30 Mar 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Pregnant women who had an EPP at Montpellier's hospital between March 2019 and March 2020.

Who may be able to join

  • No opposition from women to participate in the study
  • Women over 18
  • Women who had an EPP at Montpellier University Hospital between March 2019 and March 2020

Who cannot join

  • age < 18 years

Trial locations and contacts

1 site in 1 country.

France1 site
  • Uhmontpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Early Prenatal Interview : Throwback to the Hospital of Montpellier's Experience and Description of the Psychiatric Care Pathway of Pregnant Women.

Pregnancy and postpartum are recognized as periods of psychic fragility. However, the psychiatric disorders of women that can emerge during these periods are underdiagnosed and have consequences in particular on the development of the child, his relationship with his parents.

The need for an early diagnosis to allow appropriate treatment seems to be essential.

Read more

The pregnancy monitoring is centered on the somatic and little on psychological evaluation of the mother and the father.

In this context, the Early Prenatal Interview (EPP) was created through the perinatal plan of 2005-2007 in order to allow a more precise research of the factors of vulnerabilities likely to be predictive of a somatic, psychological or social disorder.

However, until now, only few pregnant women benefited of this interview. In May 2020, EPP became mandatory for all pregnant women. It now seems important to clearly identify the place, function, organization and usefulness of this interview in order to maximize its benefit in the monitoring of pregnancy

Read the detailed description

First, the investigators will describe the care pathway for pregnant women who have benefited of an early prenatal interview (EPP) between March 2019 and March 2020, namely continued classic follow-up or referral to a child psychiatrist / psychiatrist.

Then, the investigators will define two subgroups within the women oriented towards psychiatric follow-up: those who had this follow-up and those who did not.

Then, the investigators will identify the factors of failure of this referral to psychiatric follow-up and describe the eventual difficulties encountered by the lack of this follow-up.

Finally, the investigators will try to study these observations made with the perspective of maximizing the benefit of the Early Prenatal Interview in the monitoring of pregnancy.

Keywords
Orientation to a psychiatric follow-up after EPP, Early Prenatal Interview, Psychiatric disorder during pregnancy
Medical subject headings
Mental Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of pregnant women who have been oriented to a psychiatric follow-up after EPP.

    Percentage of pregnant women who have been oriented to a psychiatric follow-up after EPP.

    Measured: 1 day

Secondary outcomes (3)
  1. Description of the psychiatric care path after Early Prenatal Interview

    Description of the psychiatric care path after Early Prenatal Interview so :

    • percentage of pregnant women who were referred to a midwife
    • percentage of pregnant women who were referred to a child psychiatrist
    • percentage of pregnant women who were referred to an adult psychiatrist
    • percentage of pregnant women who were referred to an other follow-up

    Measured: 1 day

  2. Identification of potential factors of failure.

    Identification of potential factors of failure : In the number of women who were referral to a child psychiatrist / psychiatrist, search the number of women who didn't see the child or adult psychiatrist and try to identify why for each of these women

    Measured: 1 day

  3. Number of Participants with difficulties caused by the lack of follow-up

    Number of Participants with difficulties caused by the lack of follow-up as :

    Search for each women who were referral to a child or adult psychiatrist ;

    • mode of delivery and term
    • complications of delivery for the baby or mother
    • hospitalization in psychiatry
    • prolongation of stay in the maternity Then compare for these criterias in women who see the child or adult psychiatrist or women who didn't see him and see if the difficulties are more present in women who didn't have the follow-up

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2020
  2. Study start1 Mar 2019
  3. Primary completion1 Mar 2020
  4. Study completion30 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
1,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04574986
Sponsor's protocol ID
RECHMPL20_0452
Status last verified
Sep 2020
First submitted
11 Sep 2020
Last updated
6 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Psychiatric Disorder, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of pregnant women who have been oriented to a psychiatric follow-up after EPP. (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in